About the job
Revolution Medicines is a dynamic clinical-stage precision oncology firm dedicated to the advancement of innovative targeted therapies aimed at inhibiting critical targets in RAS-addicted cancers. Our R&D pipeline features RAS(ON) Inhibitors aimed at suppressing various oncogenic variants of RAS proteins, alongside RAS Companion Inhibitors designed for combination treatment strategies. As a new member of the Revolution Medicines team, you will join a group of exceptional Revolutionaries committed to supporting patients battling cancers with mutations in the RAS signaling pathway.
The Opportunity:
This role serves as a study-level statistician for late-stage oncology studies and provides leadership across biostatistical endeavors. The Associate Director will work collaboratively across various functions and contribute to program-level decision-making.
Represent biostatistics on study and cross-functional project teams, delivering statistical leadership.
Lead and manage biostatistical initiatives to ensure consistency, scientific rigor, and timely deliverables.
Provide statistical expertise for the design, analysis, and reporting of clinical studies.
Develop statistical analysis plans and specifications, ensuring alignment with clinical and regulatory objectives.
Collaborate with statistical programming to guarantee that analyses are performed as per the statistical plan and specifications, delivered with high quality.
Engage with data management and clinical operations to facilitate robust CRF and database development, ensuring quality data collection.
Offer statistical insights for the creation of global health authority documents, regulatory interactions, and responses to health authority submissions.
Shape strategy and inform decision-making through data-driven insights and clear communication of risks and benefits.
Collaborate in research publications, assist in data interpretation, and ensure data presentation consistency and accuracy.
Contribute to the establishment of functional-level standards, SOPs, and templates.
Stay updated on advancements in statistics, drug development, and regulatory guidance, sharing knowledge with team members.

